6 Nov - 7 Nov '18

EKITA Meeting_Strategies for improving allograft and patient survival after kidney transplantation

EKITA is the official representative body of kidney transplantation in Europe on behalf of ESOT.

The EKITA Board is proud to announce a fresh new appointment for

EKITA Meeting_Strategies for improving allograft and patient survival after kidney transplantation

Start Date:
Tuesday, 6th November, 2018 at 8:00am
End Date:
Wednesday, 7th November, 2018 at 1:00pm
Country: Germany
Description & Objectives:

EKITA is the official representative body of kidney transplantation in Europe on behalf of ESOT.

The EKITA Board is proud to announce a fresh new appointment for 2018, calling for the
participation of all those working and involved in the field of kidney transplantation. This new
educational activity aims to provide a forum for those working in the field of kidney transplantation
to exchange scientific information and views related primarily to providing the best service for
patients in Europe requiring kidney transplantation.

The meeting will stimulate and foster new developments in the area of kidney transplantation in all fields: training, organ exchange, cooperative clinical and translational research projects.
 

Target Group:

This meeting is designed for kidney transplant specialist, i.e transplant surgeons, nephrologists,
tissue typers, renal pathologists. Researches in the area will have the opportunity to engage with
clinically working colleagues to establish translational projects.

Educational Objectives

After attending this meeting, participants will be able to:

• Get a clear picture of the kidney transplant network in Europe and existing challenges and
opportunities for improvement and transnational collaborations (from KPD to clinical studies
on treatmet of the alloimmune response)

• Evaluate the studies of donor and donor organ pretreatment and outcomes and derive an
own opinion on the cost/effectiveness of these procedures.

• To derive patient tailored algorithms for the in depth diagnosis and potential therapeutic
options and effectiveness of intervention in challenging areas such as ABMR.

• Get a clear picture about the challenges and risks and policies available for the management
of the ‘third-’ and ‘fourth age’ transplant candidates.